Cell Therapy

Cell therapy involves the use of living cells or cell-derived components to support tissue repair, stimulate regeneration, and improve the function of the body’s own cells. Its purpose is to promote recovery, vitality, and overall well-being while helping address both internal health concerns and visible signs of ageing.
In the early development of cell therapy, animal organs were processed and used as treatment materials. Over time, techniques evolved to isolate specific cells and cellular components. Modern technology now allows cells to be cultivated, analysed, and selected according to their quality and functional characteristics.
Stem-cell products may vary considerably in their sources, production methods, storage conditions, cultivation standards, and quality-control processes. These factors can affect safety, consistency, and suitability for different medical applications.
Quality Standards for Stem-Cell Production
High-quality stem-cell production should follow recognised standards throughout tissue collection, cultivation, testing, storage, and preparation.
GTP: Good Tissue Practice
GTP focuses on the quality and safety of the source tissue used for cell cultivation. It aims to ensure that tissue is collected, handled, and screened appropriately to minimise contamination.
ATMP or Regulatory Standards
Advanced Therapy Medicinal Products, or ATMP, standards regulate the development and production of cell-based products for medical use.
In some countries, cell-therapy products may also be regulated by authorities such as the United States Food and Drug Administration.
ISCT Standards
The International Society for Cell & Gene Therapy provides criteria used to characterise and assess certain types of stem and stromal cells.
These criteria help determine whether the cells have the expected identity and biological characteristics.
ISO Certification
ISO standards support quality management, safety, consistency, and accuracy across different stages of laboratory and manufacturing processes.
GMP: Good Manufacturing Practice
GMP ensures that cell-based products are manufactured consistently according to controlled quality standards.
It covers areas such as:
๐ Laboratory cleanliness
๐ Staff training
๐ Equipment control
๐ Documentation
๐ Contamination prevention
๐ Product testing and traceability
Potential Applications of Cell Therapy
Cell therapy is being studied and used in different medical settings to support tissue repair and reduce inflammation.
Potential areas of application may include:
๐ Allergic and inflammatory conditions
๐ Autoimmune diseases
๐ Liver disorders
๐ Type 2 diabetes
๐ Cardiovascular conditions
๐ Neurological disorders
๐ Tendon and muscle injuries
๐ Joint degeneration
๐ Hormonal imbalance
๐ Skin ageing
๐ Hair thinning and hair loss
The suitability and expected outcome of treatment depend on the patient’s condition, the type of cells or cellular components used, and the available clinical evidence.
Cell therapy is not appropriate for every disease, and treatment should be assessed individually by a qualified doctor.
Stem Cells in the Skin and Hair Follicles
The skin contains specialised areas where stem cells are concentrated. One important area is the hair follicle bulge, often referred to as the stem-cell bulge.
These cells contribute to:
๐ Skin repair
๐ Hair-follicle regeneration
๐ Tissue maintenance
๐ Wound healing
๐ Skin strength and resilience
As people age, both the number and activity of these cells may decline. This can contribute to weaker skin, slower repair, dullness, reduced elasticity, and changes in hair growth.
Cell-based or cell-derived treatments may aim to support these natural repair mechanisms by:
๐ Increasing regenerative signals within the skin
๐ Supporting the activity of existing cells
๐ Encouraging tissue repair
๐ Improving damage associated with pollution, environmental toxins, and harsh cosmetic products
Growth Factors
Growth factors are proteins that communicate with cells and influence their behaviour.
Depending on the type of growth factor and the target tissue, they may stimulate cells to:
๐ Grow and divide
๐ Repair damaged tissue
๐ Produce collagen and elastin
๐ Form specific tissue structures
๐ Support cartilage repair
๐ Improve wound healing
๐ Stimulate hair follicles
For example, certain growth factors may encourage skin cells to produce more collagen and elastin, helping improve skin strength and texture.
Other growth factors may support cartilage cells in the joints or stimulate hair follicles to produce thicker and stronger hair.
Sources of Growth Factors
Blood is one of the most accessible sources of growth factors. It may be collected from the patient or obtained from an appropriately screened donor source.
Growth Factors from the Patient’s Own Blood
Using the patient’s own blood is known as an autologous treatment.
Its advantages include:
๐ Low risk of immune rejection
๐ Familiar biological source
๐ Reduced concern about donor-related contamination
However, the concentration and composition of growth factors may vary between individuals. Age, health status, platelet count, medication use, and preparation technique may all influence the final product.
Growth Factors from Donor Sources
Growth factors obtained from donor-derived materials may be processed and tested to control their type, quality, and concentration.
However, donor-derived products require strict screening and manufacturing standards to minimise the risks of contamination, infection, and unwanted biological reactions.
Their safety depends heavily on:
๐ Donor screening
๐ Pathogen testing
๐ Manufacturing controls
๐ Product purity
๐ Regulatory compliance
Growth Factors and PRP
PRP stands for Platelet-Rich Plasma. It is produced by processing a patient’s blood to obtain plasma with a higher concentration of platelets.
Blood consists mainly of:
๐ Plasma
๐ Red blood cells
๐ White blood cells
๐ Platelets
Platelets contain proteins and signalling molecules involved in tissue repair.
When PRP is injected into an injured or degenerative area, such as a knee joint, these substances may support the body’s natural repair response and help reduce inflammation.
Potential benefits may include:
๐ Supporting tissue recovery
๐ Reducing inflammation
๐ Improving joint function
๐ Accelerating the natural repair process
๐ Producing relatively few side effects when appropriately prepared and administered
PRP and Prepared Growth-Factor Products
The amount of growth factors in PRP cannot always be precisely controlled because platelet concentration and biological activity vary between patients.
Some people may have lower platelet counts or lower concentrations of particular growth factors, which may affect the response to treatment.
Prepared growth-factor products are designed to provide more controlled amounts or combinations of specific signalling proteins.
They may be considered for patients with mild to moderate joint degeneration, depending on the product, medical indication, and doctor’s assessment.
Some patients with moderate osteoarthritis may require a series of injections before noticing clearer improvement.
After treatment, temporary effects may include:
๐ Mild pain
๐ Tenderness
๐ Swelling
These symptoms generally improve within a few days.
Mesenchymal Stromal or Stem Cells
Mesenchymal stromal cells, often referred to as mesenchymal stem cells or MSCs, are cells capable of producing biological signals that support tissue repair and regulate inflammation.
They may be obtained from sources such as:
๐ Umbilical-cord tissue
๐ Cord blood
๐ Placental tissue
๐ Amniotic tissue
๐ Bone marrow
๐ Adipose tissue
Cells obtained from younger tissue sources may have different growth and functional characteristics from cells obtained from older individuals.
However, cell quality depends on more than the donor’s age. Other important factors include:
๐ Tissue source
๐ Collection method
๐ Processing technique
๐ Culture conditions
๐ Number of passages during cultivation
๐ Cell viability
๐ Purity
๐ Contamination screening
๐ Storage and transport conditions
Why Stem-Cell Quality Varies
Stem-cell products can differ significantly between laboratories and treatment providers.
Quality may be influenced by:
๐ Whether the source tissue was properly screened
๐ How quickly the tissue was processed after collection
๐ The laboratory environment
๐ Cell-culture techniques
๐ The methods used to select and identify the cells
๐ Testing for bacteria, viruses, fungi, and other contaminants
๐ The number of living cells in the final product
๐ Storage and thawing procedures
Price alone does not confirm the quality, safety, or effectiveness of a stem-cell product. Patients should review the production standards, regulatory status, testing documentation, and clinical evidence supporting the treatment.
Whole Cells Versus Cell-Derived Components
Although stem cells may provide regenerative and anti-inflammatory signals, whole-cell therapy is not always the most appropriate option.
In some situations, smaller cell-derived components may reach damaged tissue more easily than whole cells.
These components may include:
๐ Growth factors
๐ Cytokines
๐ Extracellular vesicles
๐ Exosomes
๐ Other cell-secreted molecules
The selection of whole cells or cell-derived products should depend on:
๐ The medical condition
๐ The target tissue
๐ The severity of the problem
๐ The available clinical evidence
๐ The patient’s health status
๐ The safety profile of the treatment
Choosing an Appropriate Cell Therapy
Cell therapy is a broad field that includes stem cells, PRP, growth factors, and other cell-derived products. Each treatment has different properties, limitations, and potential applications.
Before receiving treatment, patients should consider:
๐ The diagnosis and treatment objective
๐ The source of the cells or biological product
๐ Laboratory and manufacturing standards
๐ Regulatory approval or authorisation
๐ Evidence supporting the proposed treatment
๐ Potential risks and side effects
๐ The doctor’s qualifications and experience
๐ The treatment facility’s safety standards
A personalised medical assessment is essential because the most advanced or expensive option is not necessarily the most suitable treatment for every person.
Reference :
Независимый автор
Поделиться этой статьей
Другие статьи
Откройте для себя больше информации о здравоохранении и медицинском туризме.

Toxic Screening: Why It Matters More Than Ever?
When we hear the word “toxins,” we often imagine dangerous substances that either cause immediate harm or gradually damage health over time.

Круп у детей: симптомы, диагностика, а также как лечить и предотвращать
Ребёнок сильно кашляет? Берегитесь крупа Круп (острый ларинготрахеобронхит) — это острое инфекционное заболевание верхних дыхательных путей, часто встречающееся у маленьких детей. Обычно его вызывает вирус, который приводит к воспалению и отёку в области от гортани до мелких бронхов. В результате появляется лающий кашель, необычные дыхательные звуки и даже затруднённое дыхание.

Иммунная тромбоцитопения (ИТП) у детей: симптомы и уход
Иммунная тромбоцитопения (ИТП) у детей Иммунная тромбоцитопеническая пурпура (ИТП) — распространенное нарушение свертываемости крови у детей, вызванное низким количеством тромбоцитов. Это происходит, когда иммунная система вырабатывает антитела, которые связываются с тромбоцитами организма и разрушают их. Триггерами для выработки этих антител могут быть вирусные инфекции или некоторые лекарственные препараты, но в большинстве случаев причина остается неясной. Заболевание встречается как у младших, так и у более старших детей.